Innovita Biological Technology Valuation

Q: What is the Fair Price of 688253 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

688253 (CN¥41.72) is trading below our estimate of [[fair value]] (CN¥263.13)

Is 688253 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688253 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688253 (CN¥41.72) is trading below our estimate of fair value (CN¥263.13)

Significantly Below Fair Value: 688253 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688253?

Key metric: As 688253 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688253. This is calculated by dividing 688253's market cap by their current earnings.
What is 688253's PE Ratio?
PE Ratio	17.1x
Earnings	CN¥332.01m
Market Cap	CN¥5.69b

688253 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	5.3x
Enterprise Value/EBITDA	10.6x
PEG Ratio	0.5x

Price to Earnings Ratio vs Peers

How does 688253's PE Ratio compare to its peers?

The above table shows the PE ratio for 688253 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	39.5x
603205 Jianerkang Medical	40.9x	n/a	CN¥5.5b
301101 Mingyue Optical LensLtd	38x	14.5%	CN¥6.5b
300622 Doctorglasses ChainLtd	60x	20.5%	CN¥6.8b
688016 Shanghai MicroPort Endovascular MedTech	19.1x	20.3%	CN¥12.5b
688253 Innovita Biological Technology	17.1x	32.4%	CN¥5.7b

Price-To-Earnings vs Peers: 688253 is good value based on its Price-To-Earnings Ratio (17.1x) compared to the peer average (39.5x).

Price to Earnings Ratio vs Industry

How does 688253's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 688253 is good value based on its Price-To-Earnings Ratio (17.1x) compared to the CN Medical Equipment industry average (36.6x).

Price to Earnings Ratio vs Fair Ratio

What is 688253's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688253 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	17.1x
Fair PE Ratio	33.5x

Price-To-Earnings vs Fair Ratio: 688253 is good value based on its Price-To-Earnings Ratio (17.1x) compared to the estimated Fair Price-To-Earnings Ratio (33.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥6.7b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥15.53

-5.8%

-34.9%

Innovita Biological Technology

CN¥5.7b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥41.72

-2.1%

28.8%

Winner Medical

CN¥19.7b

Engages in the research and development, manufacture, and marketing of cotton-based medical dressings and medical disposables, and consumer products in China.

300888

CN¥33.90

5.4%

-14.7%